Summary
Sara Selitsky is a founder and executive with 11 years of experience translating bioinformatics and translational research into product-driven ventures, currently serving as CEO of FlashPath where she’s building an AI-ready safety intelligence layer. She previously led translational research at Tempus and founded QuantBio, a bioinformatics consultancy focused on preclinical and clinical oncology therapeutics development. With a PhD in Bioinformatics from UNC Chapel Hill and academic appointments there, she blends deep domain expertise in genomics and oncology with hands-on startup leadership. Sara’s career spans research, consulting, and company-building, and she’s known for turning complex biological data into actionable strategies for clinical and commercial impact. An often overlooked strength is her pattern of moving seamlessly between bench-scale science and executive strategy, accelerating translation from discovery to deployed AI-enabled safety tools.
11 years of coding experience
9 years of employment as a software developer
Bachelor's degree, Biology, General, Bachelor's degree, Biology, General at Arizona State University
Biology, General, Biology, General at University of Wyoming
Doctor of Philosophy (PhD), Bioinformatics, Doctor of Philosophy (PhD), Bioinformatics at University of North Carolina at Chapel Hill